Total Payments
$168,048
2024 Payments
$15,087
Companies
53
Transactions
666
Medicare Patients
3,726
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$130,432 (77.6%)
Consulting$16,300 (9.7%)
Food & Beverage$14,297 (8.5%)
Travel$6,986 (4.2%)
Education$32.44 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130,433 | 60 | 77.6% |
| Consulting Fee | $16,300 | 6 | 9.7% |
| Food and Beverage | $14,297 | 555 | 8.5% |
| Travel and Lodging | $6,986 | 42 | 4.2% |
| Education | $32.44 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $100,681 | 201 | $0 (2022) |
| ABBVIE INC. | $56,801 | 145 | $0 (2024) |
| PFIZER INC. | $1,691 | 21 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $804.05 | 23 | $0 (2024) |
| Intuitive Surgical, Inc. | $798.77 | 5 | $0 (2023) |
| ARGENX US, INC. | $798.26 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $709.39 | 18 | $0 (2024) |
| Biogen, Inc. | $489.48 | 8 | $0 (2023) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $434.87 | 19 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $345.21 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,087 | 154 | ABBVIE INC. ($12,196) |
| 2023 | $21,495 | 132 | ABBVIE INC. ($18,400) |
| 2022 | $36,054 | 125 | ABBVIE INC. ($25,979) |
| 2021 | $33,571 | 100 | Allergan, Inc. ($31,758) |
| 2020 | $8,678 | 33 | Allergan, Inc. ($8,475) |
| 2019 | $20,910 | 48 | Allergan Inc. ($20,453) |
| 2018 | $13,592 | 41 | Allergan Inc. ($13,259) |
| 2017 | $18,663 | 33 | Allergan Inc. ($18,245) |
All Payment Transactions
666 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: NEUROLOGY | ||||||
| 12/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $3.95 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Rare Disease | ||||||
| 12/16/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Musculoskeletal | ||||||
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.47 | General |
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $34.57 | General |
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $25.95 | General |
| Category: Narcoplepsy | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/27/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $34.14 | General |
| 11/20/2024 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Musculoskeletal | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $1.94 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $1.19 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Immunology and Neurology | ||||||
| 11/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 778 | 9,457 | $1.6M | $168,441 |
| 2022 | 20 | 801 | 28,587 | $1.1M | $272,197 |
| 2021 | 26 | 1,010 | 36,669 | $1.2M | $316,409 |
| 2020 | 34 | 1,137 | 39,742 | $1.3M | $333,615 |
Total Patients
3,726
Total Services
114,455
Medicare Billing
$1.1M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 29 | 6,712 | $217,650 | $33,097 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 322 | $282,716 | $26,414 | 9.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 64 | 195 | $157,950 | $17,805 | 11.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 105 | $182,700 | $16,977 | 9.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 38 | 235 | $153,901 | $14,523 | 9.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 119 | $145,775 | $13,081 | 9.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 41 | 42 | $101,178 | $9,616 | 9.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 43 | 44 | $74,976 | $7,146 | 9.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 13 | 32 | $38,400 | $6,014 | 15.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 28 | 75 | $51,825 | $5,486 | 10.6% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 30 | 1,241 | $26,061 | $5,228 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $56,406 | $5,172 | 9.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $55,430 | $4,029 | 7.3% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 12 | 28 | $39,546 | $3,736 | 9.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 38 | 230 | $690.00 | $116.88 | 16.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 37 | 26,674 | $498,474 | $130,807 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 161 | 275 | $156,525 | $46,534 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 161 | $92,585 | $16,909 | 18.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 54 | 159 | $56,030 | $15,456 | 27.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 54 | 54 | $36,945 | $10,700 | 29.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 37 | 37 | $39,705 | $8,896 | 22.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 32 | 129 | $31,602 | $8,641 | 27.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 38 | 38 | $24,669 | $6,344 | 25.7% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 14 | 31 | $26,187 | $5,141 | 19.6% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 19 | 32 | $18,320 | $4,678 | 25.5% |
About Dr. John Kelemen, M.D
Dr. John Kelemen, M.D is a Neurology healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811973449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kelemen, M.D has received a total of $168,048 in payments from pharmaceutical and medical device companies, with $15,087 received in 2024. These payments were reported across 666 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($130,433).
As a Medicare-enrolled provider, Kelemen has provided services to 3,726 Medicare beneficiaries, totaling 114,455 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Plainview, NY
- Active Since 12/15/2005
- Last Updated 07/09/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1811973449
Products in Payments
- BOTOX (Biological) $132,145
- BOTOX (Drug) $20,306
- BOTOX NEURO REHAB (Drug) $3,957
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $1,546
- Da Vinci Surgical System (Device) $798.77
- VYVGART (Drug) $595.28
- HYQVIA (Biological) $576.55
- ULTOMIRIS (Biological) $448.28
- UBRELVY (Drug) $391.32
- Xeomin (Biological) $345.21
- VYEPTI (Biological) $300.86
- FIRDAPSE (Drug) $250.18
- QULIPTA (Drug) $249.51
- RADICAVA (Drug) $241.91
- INGREZZA (Drug) $231.31
- WAKIX (Drug) $230.26
- Dysport (Drug) $227.84
- BOTOX-NEUROLOGY (Drug) $223.04
- VYVGART HYTRULO (Drug) $202.98
- Radicava (Drug) $192.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Plainview
Dr. Stephen Newman, M.d, M.D
Neurology — Payments: $1.2M
Neurology $1.2M
Dr. Ira Turner, M.d, M.D
Neurology — Payments: $865,285
Neurology $865,285
Jennifer Ahmed
Neurology — Payments: $27,427
Neurology $27,427
Dr. Erik Entin, M.d, M.D
Neurology — Payments: $4,988
Neurology $4,988
Dr. Vandana Soni, M.d, M.D
Neurology — Payments: $2,106
Neurology $2,106
Dr. Michael Gruttadauria, Dc, Dacan, DC, DACAN
Neurology — Payments: $10.79
Neurology $10.79